Analyst resumed coverage on PACS Group with a new price target
$PACS
Hospital/Nursing Management
Health Care
Analyst resumed coverage of PACS Group with a rating of Overweight and set a new price target of $44.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/17/2025 | $44.00 | Overweight | Analyst |
| 12/17/2024 | $18.00 | Overweight → Neutral | Analyst |
| 11/6/2024 | $40.00 | Overweight | JP Morgan |
| 10/9/2024 | $50.00 | Buy | UBS |
| 9/11/2024 | $45.00 | Buy | Citigroup |
| 6/28/2024 | $35.00 | Outperform | Macquarie |
Analyst resumed coverage of PACS Group with a rating of Overweight and set a new price target of $44.00
Analyst downgraded PACS Group from Overweight to Neutral and set a new price target of $18.00
JP Morgan resumed coverage of PACS Group with a rating of Overweight and set a new price target of $40.00
Conference Call and Webcast Scheduled for Tomorrow, May 12, 2026, at 11:30 am ET. PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced operating results for the first quarter of 2026. First Quarter 2026 Financial Highlights Revenue was $1.42 billion, an increase of 11.2% over prior year. Net income was $80.7 million, an increase of $52.3 million, or 184.2% from $28.4 million in the prior-year period. Adjusted EBITDA was $170.4 million, an increase of $72.8 million, or 74.6% from $97.6 million in the prior-year period.1 This result includes approximately
PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, today announced that it intends to release its first quarter 2026 financial results on Monday, May 11, 2026. Management will host a call on Tuesday, May 12, 2026, at 11:30 a.m. ET to discuss the financial results and related information. PACS Group invites current and prospective investors to listen to the call via webcast by going to the Investors section of the PACS Group website at https://ir.pacs.com/ or by visiting https://event.choruscall.com/mediaframe/webcast.html?webcastid=d7NGTHuZ or by dialing 877-407-0621 / 1-2
PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company") today announced that independently operated subsidiaries of the Company have acquired the operations of the post-acute care facility Ridgeway Senior Living in Anchorage, Alaska. It's the fourth PACS building in the state of Alaska. As part of the transaction, PACS has acquired land adjacent to the building, with plans to build a subsequent 150-bed skilled nursing facility, with an estimated completion date of 2028. "We're excited to expand our locally led, centrally supported model in Alaska," said Jason Murray, Chairman and Chief Executive Officer of PACS. "With our plans to build another skilled nursing center on the property, the
4 - PACS Group, Inc. (0002001184) (Issuer)
4 - PACS Group, Inc. (0002001184) (Issuer)
3 - PACS Group, Inc. (0002001184) (Issuer)
4 - PACS Group, Inc. (0002001184) (Issuer)
144 - PACS Group, Inc. (0002001184) (Subject)
8-K - PACS Group, Inc. (0002001184) (Filer)
10-Q - PACS Group, Inc. (0002001184) (Filer)
PACS Group, Inc. (NYSE:PACS), one of the nation's largest and fastest-growing post-acute healthcare platforms, today announced the appointment of Carey P. Hendrickson as its Chief Financial Officer, effective April 27, 2026. Mr. Hendrickson brings to PACS nearly four decades of financial leadership spanning public company CFO roles in healthcare, senior living, and media — a body of work distinguished by financial discipline, strategic acuity, and a consistent record of building high-performing teams that drive measurable results. His appointment marks a significant milestone for PACS as the company continues to scale its national footprint and deepen its clinical and operational leadership
Former CMS Deputy Administrator, Chief Medical Officer, and Current CEO of Optum Brings Unparalleled Clinical, Regulatory, and Healthcare Leadership to PACS Board PACS Group, Inc. (NYSE:PACS), one of the nation's largest and fastest-growing post-acute healthcare platforms, today announced the appointment of Patrick H. Conway, MD, MSc, to its Board of Directors. Dr. Conway's addition to the PACS Board represents a landmark appointment for the post-acute and skilled nursing industry — bringing to the boardroom a rare combination of hands-on clinical experience, transformative federal regulatory leadership, large-scale health system executive experience, and deep expertise in quality, value-
Conference Call and Webcast Scheduled for Tomorrow, May 12, 2026, at 11:30 am ET. PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced operating results for the first quarter of 2026. First Quarter 2026 Financial Highlights Revenue was $1.42 billion, an increase of 11.2% over prior year. Net income was $80.7 million, an increase of $52.3 million, or 184.2% from $28.4 million in the prior-year period. Adjusted EBITDA was $170.4 million, an increase of $72.8 million, or 74.6% from $97.6 million in the prior-year period.1 This result includes approximately
PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, today announced that it intends to release its first quarter 2026 financial results on Monday, May 11, 2026. Management will host a call on Tuesday, May 12, 2026, at 11:30 a.m. ET to discuss the financial results and related information. PACS Group invites current and prospective investors to listen to the call via webcast by going to the Investors section of the PACS Group website at https://ir.pacs.com/ or by visiting https://event.choruscall.com/mediaframe/webcast.html?webcastid=d7NGTHuZ or by dialing 877-407-0621 / 1-2
Conference Call and Webcast Scheduled for Today, February 26, 2026, at 5:30 pm ET. PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced operating results for the fiscal year and fourth quarter of 2025. Full Year 2025 Financial Highlights Revenue was $5.29 billion, an increase of 29.3% over prior year. Net income was $191.5 million. Adjusted EBITDA was $505.0 million. Adjusted EBITDAR was $883.9 million. Fourth Quarter 2025 Financial Highlights Revenue was $1.36 billion, an increase of 12.4% over the same period prior year. Net income was $59.
SC 13G - PACS Group, Inc. (0002001184) (Subject)
SC 13G - PACS Group, Inc. (0002001184) (Subject)
SC 13G - PACS Group, Inc. (0002001184) (Subject)